Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10362 |
| Vaccine Name | MK-1654 |
| Disease Name | Respiratory syncytial virus infection |
| Disease Classification | Respiratory |
| Virus Name | Respiratory syncytial virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | NA |
| Vaccine Status | Phase 3 |
| Manufacturer | Merck & Co. Inc. |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | upto 1 year |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Fusion glycoprotein of RSV |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04938830 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT04938830?recrs=bde&cond=Respiratory+Syncytial+Virus+%28RSV%29&phase=23&draw=2&rank=12 |
| Additional Links | https://ichgcp.net/clinical-trials-registry/NCT04938830 |